Vaccine News and Research

Latest Vaccine News and Research

Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain

Crotoxin, extracted from the venom of the South American rattlesnake Crotalus durissus terrificus, has been studied for almost a century for its analgesic, anti-inflammatory and antitumor activities and as an even more powerful muscle paralyzer than botulinum toxin.

16 Feb 2020

Creating a better future for victims of child abuse and neglect

Every child has the right to health and a life free from fear and violence. Yet, each year, millions of children endure inconceivable physical, sexual and emotional abuse and chronic neglect.

13 Feb 2020

Study gives clues on how to stop HIV reemergence

A new study released today in the Journal of Virology gives insights into how the HIV-1 virus, which often persists in the body despite antiretroviral treatment, reemerges when treatment stops. More importantly, the study also gives clues on how to stop this reemergence from occurring.

12 Feb 2020

Shingles vaccine appears to reduce stroke risk

New research has revealed that older adults who regularly golf could be at a lower risk of death compared to those who do not play. The results of this research are to be presented at the American Stroke Association's International Stroke Conference 2020 in Los Angeles between the 19th and 21st of February 2020.

12 Feb 2020

Researchers engineer probiotics to safely deliver immunotherapies to tumors

Researchers at Columbia Engineering have engineered probiotics to safely deliver immunotherapies within tumors.

12 Feb 2020

A happy and positive partner will make you healthier

A new study says that having a happy and optimistic partner may help you become healthier, preventing cognitive decline.

12 Feb 2020

2019 coronavirus virus officially named COVID-19

The novel coronavirus disease, which has spread from China to 24 other countries around the globe, has received its official name – COVID-19, the World Health Organization (WHO) said.

12 Feb 2020

Recent progress in TB diagnostics and prevention approaches offers hope for future

In September 2018, the National Institute of Allergy and Infectious Diseases, part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the burden of tuberculosis.

11 Feb 2020

The U.S. can erase cervical cancer in two decades

Cervical cancer is preventable, thanks to the development of the human papillomavirus (HPV) vaccine. Various strains of HPV, a sexually transmitted infection, play a significant role in the event of cervical cancer. Now, the U.S. can eradicate cervical cancer within the next 20 years, according to a new study.

11 Feb 2020

Coronavirus app detects if you’ve been exposed

The novel coronavirus (2019-nCoV) can spread rapidly, with at least a thousand new infections and a hundred of deaths each day. The epicenter of the outbreak, Wuhan in China, has been locked down since the peak of the outbreak. Now, Chinese officials say they’ve developed a new coronavirus app that tracks people and alerts them if they have been in close contact with the deadly virus.

11 Feb 2020

Major breakthrough in understanding how malaria parasite grows and multiplies

Scientists have made a major breakthrough in understanding how the parasite that causes malaria is able to multiply at such an alarming rate, which could be a vital clue in discovering how it has evolved, and how it can be stopped.

11 Feb 2020

Young sexual minority men do not fully understand their risk for HPV infection

Young sexual minority men -- including those who are gay, bisexual, queer or straight-identified men who have sex with men -- do not fully understand their risk for human papillomavirus due to a lack of information from health care providers, according to Rutgers researchers.

11 Feb 2020

New prophylactic and therapeutic avenues to fight against rabies

Rabies is still responsible for approximately 60,000 human deaths per year mostly in Asia and Africa and affects especially underserved people.

11 Feb 2020

Developing enhanced personalized cancer vaccines

Therapeutic cancer vaccines were first developed 100 years ago and have remained broadly ineffective to date. Before tangible results can be achieved, two major obstacles must be overcome.

11 Feb 2020

PolyU develops fully automated, rapid diagnostic platform for detecting respiratory infectious diseases

The Hong Kong Polytechnic University today announced the development of the world's most comprehensive automated multiplex diagnostic system (the System) which includes a fully automated machine and a multiplex full-screening panel for the point-of-care genetic testing of respiratory infectious disease including the 2019-nCoV.

11 Feb 2020

Blue Water Vaccines enters into agreement to develop Streptococcus pneumoniae vaccine with St. Jude

Blue Water Vaccines Inc., a biopharmaceutical company focused on creating transformative vaccines solving global health challenges, has entered into an exclusive worldwide license agreement for the development of a Streptococcus Pneumoniae vaccine with St. Jude Children's Research Hospital, the nation's leading hospital dedicated to understanding, treating and curing childhood cancer and other life-threatening diseases.

11 Feb 2020

Australian scientists grow live coronavirus virus

The novel coronavirus (2019-nCoV) is rapidly spreading across the globe, with the highest magnitude taking a toll on mainland China. Scientists are racing to find a vaccine or a treatment to help contain the virus spread. Now, a team of scientists and health experts in Australia may have found a breakthrough to fight the deadly virus.

11 Feb 2020